Farrell, Emma https://orcid.org/0000-0002-7780-9428
Nadglowski, Joseph
Hollmann, Eva
le Roux, Carel W. https://orcid.org/0000-0001-5521-5445
McGillicuddy, Deirdre https://orcid.org/0000-0002-0548-8004
Article History
Received: 10 April 2024
Revised: 14 August 2025
Accepted: 11 September 2025
First Online: 31 October 2025
Change Date: 18 November 2025
Change Type: Update
Change Details: The original online version of this article was revised: In this article, the order in which the authors appeared in the author list was incorrectly given as Emma Farrell, Joseph Nadglowski, Eva Hollmann, Deirdre McGillicuddy and Carel W. le Roux where it should have been Emma Farrell, Joseph Nadglowski, Eva Hollmann, Carel W. le Roux and Deirdre McGillicuddy. The original article has been corrected.
Change Date: 22 November 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41366-025-01964-6
Competing interests
: ClR has served on advisory boards for Novo Nordisk, GI Dynamics, Keyron, Sanofi, Boehringer Ingelheim, Herbalife, Johnson and Johnson, whilst receiving grant funding from Science Foundation Ireland, The Health Research Board and the Irish Research Council. The other authors have no conflicts of interest to report.
: Ethical approval for this study was granted by UCD’s Human Research Ethics Committee (HS-20-12-McGillicuddy) and all methods were performed with the relevant ethical guidelines and regulations. Participants were aware that they could withdraw their participation at any stage without consequence. Informed consent was obtained from participants both in written form, in response to the study information sheet, and verbally before each interview and focus group.